Elevated dementia risk even when pollution is below EPA standards

BoldThemesFebruary 15, 2024
Exhaust from a diesel vehicle.

Health

Elevated dementia risk even when pollution is below EPA standards


3 min read

Using new analysis tool, researchers find consistent evidence associating PM2.5 and cognitive decline

Exposure to fine particulate air pollutants (PM2.5) may increase the risk of developing dementia, according to a new meta-analysis from Harvard T.H. Chan School of Public Health.

This study is the first systematic review and meta-analysis to use the new Risk of Bias In Non-Randomized Studies of Exposure (ROBINS-E) tool, which addresses bias in environmental studies in greater detail than other assessment approaches. It also is the first to include newer studies that used “active case ascertainment,” a method that involved screening of entire study populations followed by in-person evaluation for dementia among individuals who did not have dementia at baseline.

“This is a big step in providing actionable data for regulatory agencies and clinicians in terms of making sense of the state of the literature on this hugely important health topic. The results can be used by organizations like the Environmental Protection Agency, which is currently considering strengthening limits on PM2.5 exposure,” said lead author Marc Weisskopf, Cecil K. and Philip Drinker Professor of Environmental Epidemiology and Physiology. “Our findings support the public health importance of such a measure.”

The study was published online Wednesday in The BMJ.

More than 57 million people worldwide are currently living with dementia, and estimates suggest that number will increase to 153 million by 2050. Up to 40 percent of these cases are thought to be linked to potentially modifiable risk factors, such as exposure to air pollutants.

Researchers scanned more than 2,000 studies and identified 51 that evaluated an association between ambient air pollution and clinical dementia, all published within the last 10 years. Those studies were assessed for bias using ROBINS-E, and 16 of them met the criteria for the meta-analysis. The majority of the research was about PM2.5, with nitrogen dioxide and nitrogen oxide being the next most common pollutants studied. Of the studies used in the meta-analysis, nine used active case ascertainment.

Up to 40 percent of dementia cases are thought to be linked to potentially modifiable risk factors, such as exposure to air pollutants.

The researchers found consistent evidence of an association between PM2.5 and dementia, even when annual exposure was less than the current EPA annual standard of 12 micrograms per cubic meter of air (μg/m3). In particular, among the studies using active case ascertainment, the researchers found a 17 percent increase in risk for developing dementia for every 2 μg/m3 increase in average annual exposure to PM2.5. They also found evidence suggesting associations between dementia and nitrogen oxide (5 percent increase in risk for every 10 μg/m3 increase in annual exposure), and nitrogen dioxide (2 percent increase in risk for every 10 μg/m3 increase in annual exposure), though the data was more limited.

The researchers noted that air pollution’s estimated association with risk of dementia is smaller than that of other risk factors, such as education and smoking. However, because of the number of people exposed to air pollution, the population-level health implications could be substantial.

“Given the massive numbers of dementia cases, identifying actionable modifiable risk factors to reduce the burden of disease would have tremendous personal and societal impact,” Weisskopf said. “Exposure to PM2.5 and other air pollutants is modifiable to some extent by personal behaviors — but more importantly through regulation.”

Weisskopf’s co-authors were Elissa Wilker, researcher in the Harvard Chan-NIEHS Center for Environmental Health, and Marwa Osman, a doctoral student in the Biological Science in Public Health program.

Funding for the study came from Biogen and from National Institutes of Health grants P30 ES000002 and T32 HL007118.